CLINICAL_TRIALS trial_result · 2024-03-22

Clinical Trial Update: A Trial to Assess the Efficacy and Safety of 400mg/Day Lacosamide in Subjects With Painful Diabetic Neuropathy [Phase 3]

A Phase 3 trial assessing efficacy and safety of 400 mg/day lacosamide in painful diabetic neuropathy has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: UCB Pharma | Conditions: Painful Diabetic Neuropathy | Phase 3 | Status: COMPLETED | Results posted: 2024-03-22